Implantable acousto-optic window for monitoring ultrasound-mediated neuromodulation in vivo
Sungho Lee, Keunhyung Lee, Myunghwan Choi, Jinhyoung Park
Neurophotonics 2022 · 10.1117/1.nph.9.3.032203
Abstract
Significance: Ultrasound has recently received considerable attention in neuroscience because it provides noninvasive control of deep brain activity. Although the feasibility of ultrasound stimulation has been reported in preclinical and clinical settings, its mechanistic understanding remains limited. While optical microscopy has become the "gold standard" tool for investigating population-level neural functions in vivo , its application for ultrasound neuromodulation has been technically challenging, as most conventional ultrasonic transducers are not designed to be compatible with optical microscopy. Aim: We aimed to develop a transparent acoustic transducer based on a glass coverslip called the acousto-optic window (AOW), which simultaneously provides ultrasound neuromodulation and microscopic monitoring of neural responses in vivo . Approach: The AOW was fabricated by the serial deposition of transparent acoustic stacks on a circular glass coverslip, comprising a piezoelectric material, polyvinylidene fluoride-trifluoroethylene, and indium-tin-oxide electrodes. The fabricated AOW was implanted into a transgenic neural-activity reporter mouse after open craniotomy. Two-photon microscopy was used to observe neuronal activity in response to ultrasonic stimulation through the AOW. Results: The AOW allowed microscopic imaging of calcium activity in cortical neurons in response to ultrasound stimulation. The optical transparency was ∼ 40 % over the visible and near-infrared spectra, and the ultrasonic pressure was 0.035 MPa at 10 MHz corresponding to 10 mW / cm 2 . In anesthetized Gad2-GCaMP6-tdTomato mice, we observed robust ultrasound-evoked activation of inhibitory cortical neurons at depths up to 200 μ m . Conclusions: The AOW is an implantable ultrasonic transducer that is broadly compatible with optical imaging modalities. The AOW will facilitate our understanding of ultrasound neuromodulation in vivo .
Abstract via europepmc.
Exposures
Exposure 1: Acousto-optic window (implanted transparent PVDF-TrFE transducer) on somatosensory cortex
Target: primary somatosensory cortex — “somatosensory cortex”
Device: custom-built · acousto-optic window (AOW) ✓
| Waveform | pulsed | |
|---|---|---|
| Fundamental frequency (kHz) | 10,000 | ✓✓✓⚑ |
| Pulse duration (ms) | not reportedimplied by duty cycle ÷ PRF: 0.3333 ms (not stated by the paper) | ⚑ |
| Pulse repetition frequency (Hz) | 1,500 | ✓✓✓ |
| Duty cycle (%) | 50 | ✓✓✓ |
| Sonication duration (s) | 1, 20swept | ✓✓✓ |
| Free-field pressure (kPa) | not reported | |
|---|---|---|
| Free-field Isppa (W/cm²) | not reported | |
| Free-field Ispta (W/cm²) | not reported | |
| In-situ estimate | not reported | |
| In-situ pressure (kPa) | not reported | |
| In-situ Isppa (W/cm²) | not reported | |
| In-situ Ispta (W/cm²) | not reported | |
| Pressure, domain unspecified (kPa) | 35 | ✓✓✓⚑ |
10 MHz, PRF 1.5 kHz, duty cycle 50 %, with 'pulse length' of 1 to 20 s (Fig. 3b); stimulation periods of 1, 5, 10 and 20 s were compared. The transducer sat directly on the cortex after open craniotomy.
Flags from extraction
exposures[0].timing.pulse_duration_ms— 'Pulse length' in the Fig. 3b caption is 1 to 20 s, i.e. the stimulation train, not the individual pulse. Individual pulse duration is not stated (DC/PRF would be about 0.33 ms; not computed).exposures[0].unspecified_domain.pressure_kpa— Abstract gives 0.035 MPa 'corresponding to 10 mW/cm2' without saying which intensity metric; the stated pressure is not tied to water or tissue. 10 mW/cm2 was not recorded. Hydrophone measurements in water (e.g. 0.11 MPa axial maximum at 60 Vpp, 3 cycles) used different drive settings.n_subjects— Three mice stated for the stimulation-duration experiment; total number of mice used for Fig. 4b not given.exposures[0].device.family— Transducer fabricated by the authors (PVDF-TrFE and ITO on a coverslip); the transducer is implanted on the cortex after craniotomy, not transcranial.exposures[0].fundamental_frequency_khz— 10 MHz recorded as 10000 kHz; pulse-echo centre frequency of the device was 24 MHz, with the 10 MHz being the lowest usable -6 dB frequency.